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Abstract 
 
von Euler, H., 2002. Electrochemical treatment of tumours. Doctor￿s dissertation. 
ISSN 1401-6257, ISBN 91-576-6386-6. 
 
By electrochemical treatment (EChT) neoplastic tissue is supplied with a 
continuous direct current through two or more electrodes placed in or near the 
tumour. The EChT has been taken under serious consideration as being one of 
several techniques for local treatment of malignancies. The advantage of the 
therapy is the minimal invasive approach and few serious side effects. EChT has 
not yet been universally accepted due to the absence of essential preclinical studies 
and controlled clinical trials. Uncertainties regarding the destruction mechanism of 
EChT also hinder the development of an optimised and reliable methodology for 
serving as a complement in the oncologic treatments used in the Western world. 
This thesis investigates the correlation between the pH profile in the tissue 
surrounding the electrodes and the macroscopic, histopathological and 
ultrastructural tissue destruction obtained after EChT. Experiments designed to 
display both the normal, as well as tumour tissue response, is described. A 
separation between the polarities of the electrodes has been assured to allow 
specific examinations of the different reactions. To verify the relation between cell 
damage and pH an in vitro model was conducted where tumour cells were exposed 
to a pH gradient. To investigate if the same destructive mechanisms could be 
observed in tumour tissue in vivo an animal model was performed with the same 
cell line. The in vivo experiments also served as a control and calibration of a 
mathematical dose-planning model. 
To examine the change of pH in tissue extensive in situ pH-measurements were 
performed with a micro-combination glass electrode. 
The distribution of the lesions was predictable, irrespective of dose and electrode 
configuration. Destruction volumes were found to fit into a logarithmic curve 
(dose-response). Histopathological examination confirmed the macroscopically 
detectable lesions. The type of necrosis differed due to electrode polarity. Ultra-
structural analysis showed distinct features of cell damage depending on the 
distance from the electrode. Histopathological and ultra-structural examination 
demonstrated that the tissue close to the border of the lesions displayed a normal 
morphology. 
In the tumour model in vivo, significant changes in proliferation rate were seen 
both in the cathode and anode reaction. Apoptosis were induced in the anodic 
treatment suggesting that secondary cell destruction was caused by necrosis with 
cathodic EChT and apoptosis or necrosis at the anode. The findings agree with the 
results from the in vitro experiment. 
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by their Roman numerals. 
 
I.   von Euler, H., Nilsson, E., Lagerstedt, A-S. and Olsson, J.M. 1999. 
Development of a dose-planning method for electrochemical treatment of tumors. 
A study of mammary tissue in healthy female CD-rats. Electro- and 
Magnetobiology, 18, 93-105. 
 
II.    von Euler, H., Nilsson, E., Olsson, J.M. and Lagerstedt, A-S. 2001. 
Electrochemical treatment (EChT) effects in rat mammary and liver tissue. In vivo 
optimizing of a dose-planning model for EChT of tumours. Bioelectrochemistry, 
54, 117-24. 
 
III.   von Euler, H., S￿derstedt, A., Th￿rne, A., Olsson, J.M. and Yongqing, G. 
2002. Cellular toxicity on the R3230AC rat mammary tumour cell line by a pH-
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proliferation and apoptosis in rat mammary cancer after electrochemical treatment 
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Abbreviations and definitions 
 
A        A m p e r e  
BrdU     5-Bromo-2￿-deoxyuridine 
C       Coulomb  (Ampere  second;  As) 
CFN     Centrala  F￿rs￿ksdjursn￿mnden  or   
The Swedish National Board for Laboratory Animals 
CD      A  Sprague  Dawley  rat 
CPP32    Caspase-3 
EChT     Electrochemical  treatment 
g       gravitational  constant 
i.p.      Intraperitoneal 
Ir       Iridium 
mA      Milliampere 
MTT     3-(4,5-dimethylthiazol-2-yl)-2,5,-diphenyl  tetrazolium  bromide 
PCM     Phase  contrast  microscope 
P t       P l a t i n u m  
RER     Granular  endoplasmic  reticulum 
Rhodium   Rh 
rpm      revolutions  per  minute 
RPMI 1640 A cell culture media 
V        V o l t  
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Introduction 
 
In Electrochemical Treatment (EChT) of tumours electrolysis is used to destroy 
tumour tissue. Several contributory factors seem to be involved in the tissue 
destruction. Their respective roles in producing the anti-tumour effects are not 
fully understood. Mans fascination of the power of electricity and its use in 
oncology spans from the late 18
th century. A short overview of landmarks in the 
use of different electrical applications is shown in table 1. Reports of the use of 
EChT can be found as far back in history as the mid 19
th century (Crussel, 1847). 
Although it is hard to critically review these experiments a few attempts have been 
made to describe the use of EChT (Schechter, 1979; Watson, 1991; Nordenstr￿m, 
1994b; Nilsson, von Euler et al., 2000). The modern history of electrochemical 
treatment started 1959, when Humphrey and Seal reported encouraging results 
with sarcoma tumours in mice (Humphrey & Seal, 1959). After this a number of 
trials were conducted in which animal tumour models and in vitro experiments 
would serve as a base for the introduction of EChT in the clinical setting.  
 
Table 1. Electrotherapeutic approaches to tumour destruction 
 
Treatment mode  Treatment principle  References 
Static electricity  Surface electrification by anodyne or counter-
phlogistic actions. 
(Cavallo, 1777) 
Electrocautery  Electrothermic coagulation using multiple metallic 
hooks or wire electrodes. 
(Duchenne, 1872) 
Electrolysis or 
electrochemical 
treatment 
Electrolytic destruction of tissue after application of 
platinum electrodes into the tumour. 
(Crussel, 1847) 
Electroatrophy  Application of abrupt alternating current across 
needles, which included both poles within the 
tumour. 
(Inglis-Parsons, 
1893) 
Cataphoresis  Amalgamation of gold electrodes with salts of 
mercury and by electrical diffusion impregnating the 
tumour with tumouricidal doses of mercury. 
(Massey, 1898; 
1914; 1924) 
Electrostatic treatment  An electrode inserted into an organ is 
electrostatically charged in relation to ground. A 
field of the same polarity as the electrode is created. 
(Nordenstr￿m, 
1983) 
Electrophoretic 
chemotherapy 
Electrophoretic transportation of electrically 
charged chemotherapeutic drugs through the tumour 
tissue or electric attraction of the charged drug into 
the tumour tissue. 
(Nordenstr￿m, 
Eksborg et al., 
1990) 
Electropermeabilization  Very short (100 ￿sec) intense (1300 V/cm) pulses 
administered through two external electrodes 
located on each side of the treated nodule, used in 
combination with chemotherapy. 
(Mir, Belehradek 
et al., 1991) 
 
 
 
 The electrolysis 
When two or more electrodes are inserted into the tissue a series of 
electrochemical reactions are taking place. When a practically insoluble electrode 
material such as platinum is used, the main electrode reactions are decomposition 
of water along with oxidation and reduction of substances dissolved in the tissue. 
At the anode the evolution of oxygen as well as acidification and formation of 
chlorine occur: 
 
 
2H2O  
→
←  O2 +  4H
+ + 4 e
-                                 (1) 
-
2
- 2e   +   Cl      Cl 2   ←
→
                                             (2) 
In addition, chlorine might react with water causing further acidification: 
                 
-
Cl    +   H   +   HClO       O H Cl
+
2 2 ←
→
+                               (3) 
Experimental results as well as theoretical estimations have indicated that the 
spreading of hydrogen ions in tissue surrounding the anode is considerably larger 
than the spreading of chlorine (Berendson & Olsson, 1998). At the cathode, water 
is decomposed into hydrogen and hydroxyl ions: 
 
-
2
-
2 2OH   +   H       2e   + O H 2 ←
→
                                (4) 
Due to the formation of acidic and basic heamatin, the tissue surrounding the 
anode and cathode becomes dark brown (Lemberg & Legge, 1949). The acidic 
heamatin contains methaemoglobin whilst the dark area around the cathodic lesion 
consists of haemochromogens (Samuelsson & Jonsson, 1980; 1981). The 
spreading of chlorine causes a grey coloured zone close to the anode, which is 
considerably smaller than the heamatin zone (Samuelsson & Jonsson, 1981). 
 
The delivered charge (dose) is usually expressed in Coulomb (C). Coulomb is a 
unit of electrical charge equal to the amount of charge transferred by a current of 1 
ampere in 1 second (As). Different strategies have been applied for treatments; 
some researchers have used constant voltage and a variable current, while others 
have kept the current constant to let the voltage vary instead. For both methods the 
Coulomb dose can be determined. A schematic of the EChT treatment and 
electrolysis is shown in figure 1. 
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Figure 1. A schematic on the principle for electrochemical treatment of tumours. 
 
The Swedish experience 
One of the pioneers in Sweden was the professor in radiology Bj￿rn Nordenstr￿m 
who in the mid eighties published a series of reports on EChT of human tumours 
(Nordenstr￿m, 1983; 1989). He treated lung metastases (carcinomas) and a few 
primary lung tumours. Many of the patients were, for various reasons, unsuitable 
for surgical, radiotherapeutic, or chemotherapeutic treatment. The average 
delivered coulomb (C) dosage was 80 C/cm of tumour diameter. Regression was 
obtained in 12 out of 26 tumours and no signs of progression were detected after a 
2￿5-year follow-up period in these cases. There was no reported lethal outcome of 
the therapy, although tumours with a diameter larger than 3 cm did not always 
respond well to the treatment. One woman had a big metastasis (4 cm) and three 
other between 1-2 cm in diameter, one situated in the right and two in the left lung. 
After EChT the tumours disappeared and she is still alive, more than 20 years after 
the treatment. Among the side effects, Nordenstr￿m noticed slight fever, one 
postoperative pneumothorax and local pain during EChT.  
 
Professor Nordenstr￿m also used combination therapies between EChT and 
chemotherapy. In a couple of reports Nordenstr￿m and colleagues investigated the 
additive effect of Doxorubicin with EChT (Eksborg, Nordenstr￿m et al., 1990; 
Nordenstr￿m, Eksborg et al., 1990). Some positive responses could be detected in 
a group of 14 patients with large lung neoplasms, incurable with conventional 
cancer therapy (Nordenstr￿m, Eksborg et al., 1990). 
 
Despite the promising results of EChT the technique gained a low interest among 
colleagues in Sweden and the rest of the Western world.  
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The Chinese experience 
In the republic of China EChT is seen as a good complement in the treatment of 
tumours since it is considered inexpensive compared to other traditional 
techniques and reliable. The results of the Chinese experience have been presented 
in numerous conferences and reports (Matsushima, Takahashi et al., 1994; Xin, 
1994; 1998). At first, the reports were not taken seriously in the Western world 
due to the poor quality. This has changed and recently many papers have been 
published from groups in Europe, USA and Australia that use different variants of 
the techniques described by the Chinese (Robertson, Wemyss-Holden et al., 1998; 
Turler, Schaefer et al., 2000; Wemyss-Holden, Hall et al., 2000; Wemyss-Holden, 
Robertson et al., 2000). Up to the present day, more than 15 000 treatments of 
human tumours have been preformed in China. A summary of the results can be 
found in a review from 2000, by Nilsson and co-workers (Nilsson, von Euler et 
al., 2000).  
 
The destructive mechanisms 
Electric field and Chlorine 
Many suggestions have been made on which should be the main cause of tissue 
destruction after electrochemical treatment. Some authors claim that the electric 
field has an important impact on cell death or tumour tissue remodelling 
(Vodovnik, Miklavčič et al., 1992; Nordenstr￿m, 1994a; Vijh, 1999). The electric 
field causes a flux of interstitial water, electro-osmosis, from the anode towards 
the cathode, since the water molecules act like a dipole. Consequently, the tissue 
surrounding the anode dehydrates while oedema is obtained around the cathode 
(Nordenstr￿m, 1983; Vijh, 1999). Charged substances, dissolved or suspended in 
tissue, migrate in the electric field and accumulation of ions and charged tissue 
constituents are obtained at certain and different locations in the electric field. The 
electric field influences the ion exchange across the cell membranes. Hence, the 
transmembrane potential is altered and thereby the conditions e.g. for many 
essential enzyme-regulated reactions (Nordenstr￿m, 1983; Vodovnik, Miklavčič et 
al., 1992).  
 
Others have considered chlorine (Cl) as being the most toxic factor (Samuelsson & 
Jonsson, 1980; Samuelsson, Olin et al., 1980).  
 
The impact of pH 
With little doubt though, most reports have elucidated the extreme pH-gradient 
that occurs at EChT. At the anode, as low pH as 1 has been measured 
(Nordenstr￿m, 1983; Miklavčič, Ser￿a et al., 1993). While at the cathode the 
prominent alkalisation yields pH levels as high as 13 (Nordenstr￿m, 1983; Li, Xin 
et al., 1997). At these extreme pH values, the tissue proteins become denaturated 
and the cell structure collapses and the cell eventually dies (Lemberg & Legge, 
1949; Nordenstr￿m, 1983; Li, Xin et al., 1997).  
   13
The pH changes during EChT have also been predicted through many theoretical 
calculations. Berendson et al. studied the spreading of hydrogen ions and 
molecular chlorine around spherical and planar platinum anodes (Berendson & 
Simonsson, 1994; Berendson & Olsson, 1998). Nilsson et al. have investigated the 
formation and spreading of potential toxic species around both the anode and 
cathode, preferably with a spherical electrode configuration (Nilsson, Fontes et al., 
1998; 1999; Nilsson & Fontes, 2001). 
 
Dissolved ions 
The above are correct in an environment were the treatment electrodes are inert. If 
the electrode is made from a soluble material such as Copper (Cu), Rhodium (Rh) 
or brass (Zn-Cu alloy) the electrolysis causes metal ions to dissolve in the tissue 
(Samuelsson, Jonsson et al., 1991). In that case, the metal ions can have toxic 
capacity by themselves. 
 
Miklavčič, Ser￿a and co-workers, have shown both the importance of the pH 
change in tissue during EChT as well as the formation of metal ions during 
electrolysis when using other materials than Platinum (Pt) (Miklavčič, Fajgelj et 
al., 1994). In their experiments they also showed that the intralesional temperature 
change is marginal and hence, most likely, do not influence the cell survival 
(Miklavčič, Ser￿a et al., 1993). 
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Aims of the study 
 
The aim of this study was to investigate how electrochemical treatment affects 
normal and tumour tissue. Moreover, interest was focused on whether the 
electrode polarity mattered in terms of destruction type and treatment efficacy. In 
addition to the work in different tissues and cell cultures, the thesis includes parts 
of an earlier described dose-planning model. The results from this thesis enable an 
investigation of the validity of the mathematical models, as well as of their 
applicability for dose planning. This was done: 
 
- by studying the correlation between the pH profile in the tissue surrounding the 
electrodes and the macroscopic, histopathological and ultrastructural tissue 
destruction obtained directly after terminated EChT.  
 
- by studying the reactions with a single electrode configuration. In all 
experiments a separation between the polarities of the electrodes have been 
assured to allow specific examinations of the different reactions occurring around 
the anode and the cathode, respectively.  
 
- by studying the cellular response to unphysiologic pH. To verify the relation 
between cell damage and pH an in vitro model was conducted where tumour cells 
were exposed to a pH gradient.  
 
- by studying the EChT effect in tumour tissue. To investigate if the same 
destructive mechanisms could be observed in tumour tissue in vivo an animal 
model was preformed with the same cell line that had formerly been used in vitro.  
 
- by studying the accuracy of an earlier described theoretical model. The in vivo 
experiments also served as a control and calibration of a mathematical dose-
planning model. 
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Materials and methods 
 
Ethics  
Every step has been taken to follow the guidelines from the The Swedish National 
Board for Laboratory Animals (CFN) to Reduce, Refine and Replace experiments 
with animals. Some animal experiments have been Replaced by performing the pH 
exposure to rat mammary cancer cells in vitro (Paper III) and hereby Reduced the 
number of animals used in the tumour inoculation model (Paper V) to a minimum, 
since we already knew what damages to expect and only wanted to verify that the 
same mechanisms are occurring in vivo. The experiments were also Refined by 
using a lot of time to create the protocols and conduct as many terminal 
experiments possible, where the animals were treated under general anaesthesia 
and euthanised without first waking up. Due to this, the amount of pain and 
discomfort during the trial has been minimised. 
 
Treatment with EChT in adult female CD rat mammary and liver tissue complies 
with the decision of the Swedish animal ethical committee C 112/96. The 
treatment of liver tissue in dog complies with decision nr C 76/99 while the 
tumour model in rats complies with the code S 84/00. 
 
The methodology and results will only be described briefly since it has already 
been thoroughly penetrated in the papers included in the thesis. 
 
Normal rat mammary tissue (Paper I) 
To study the effect of electrochemical treatment on normal tissue, mammary gland 
in 52 adult female rats weighing 270-350 g, were treated (1-5 mA, 10-85 min) 
under general anaesthesia using midazolam (Dormicumﬁ, Roche, Stockholm) 1.2 
mg/ml and fentanyl-fluanisone (Hypnormﬁ, Janssen Animal Health, 
Buckinghamshire, UK) diluted 1:4, which was injected i.p. 0.3 ml/100 g 
(Flecknell, 1993), in a terminal (acute) experiment. A heating lamp was placed 20 
cm above the animal to decrease hypothermia. Constant direct current was used in 
order to investigate the influence of current level, treatment time and coulomb 
dosage on tissue destruction. The electrodes used were Platinum:Iridium (Pt:Ir) 
(9:1) with spherical tips. Extensive in situ pH-measurements were performed with 
a micro-combination glass electrode (MI-413, Microelectrodes Inc., USA) encased 
in an 18-gauge stainless steel needle. The tip of the needle had a diameter of 1.3 
mm. The electrode was designed for measurements in the pH range of 0-14. The 
equipment used for EChT is shown in Figure 2.  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. The equipment used for EChT. In the background the potentiostat is seen. In the 
foreground a Palm pilot IIIXe is attached to a portable keyboard. 
 
Macroscopic examination of treated mammary tissue revealed an almost spherical 
necrosis with heavy dark colour due to the heamatin produced during EChT. 
Histological examination showed that the direct current induced two different 
types of necrosis depending on the polarity of the electrode. Firstly, at the anode, a 
coagulative necrosis with pycnotic nuclei, intravascular thrombosis and 
extravasation of blood cells was obtained. Although it appeared that the 
histological architecture was still rather evident, the tissue was suffering from 
severe dehydration. On the other hand, at the cathode, a prominent oedema with 
large, vacuolarly degenerated nuclei (hypoosmosis) and lysed erythrocytes 
appeared. It was harder to follow the original structure of the tissue. Consequently, 
the border between oedematous, damaged tissue and intact tissue was not as clear 
as in the anodic section.  
 
Steep pH profiles, with pH values switching from unphysiological to neutral status 
within only a few millimetres, were obtained in tissue surrounding the electrodes. 
Significant differences P<0.05 (paired t-tests), in lesion sizes and pH profiles were 
obtained when using a wide range of currents while holding the coulomb dosage 
constant. The pH at the border of the anodic and cathodic lesions correlated well 
to certain values, 4.5 to 5.5 at the anode and between 9 to 10 at the cathode, 
irrespective of current or coulomb dosages delivered. This indicates that in a 
clinical situation pH values known to cause total tissue destruction could be used 
as markers to evaluate the efficacy of treatment. 
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Comparison between EChT in normal rat mammary and liver 
tissue (Paper II) 
This study compared results from treatment of liver and mammary tissue focusing 
on destruction and pH changes in the tissue close to the treatment electrodes. 
Subsequently, data were compared with a dose-planning model.  
Mammary or liver tissue in 50 adult female Sprague Dawley rats (CD) was given 
EChT with a constant, direct current (1-5 mA, 18-85 min). The electrodes used 
were Pt:Ir (9:1) with spherical tips. In situ pH measurements were taken with a 
micro-combination glass electrode as earlier described in Paper I. All rats tolerated 
the treatment well. The animals were euthanased after EChT without first waking 
up. 
 
Spherical lesions were produced in both liver and mammary tissue. No significant 
difference (paired t-tests) was detected when comparing the size of the lesions in 
the two kinds of tissue.  
 
Similar pH profiles were obtained in tissue surrounding the electrodes, with pH 
values changing from unphysiological to neutral status within the space of a few 
millimetres. One clear difference was that in all treatment groups, the liver tissue 
proved to be significantly more acidic close to the anode, and more alkaline close 
to the cathode than did mammary tissue. The pH at the border of the macroscopic 
destruction zone, regardless of tissue type or coulomb dosage, correlated well with 
specific values already described in Paper I.  
 
The mathematical dose-planning simulations indicated that in tissue surrounding 
the anode, the pH profile continued to change, due to diffusion and chemical 
reaction, with time after the current had been cut. At the lower amperage (1 mA), 
the experimental pH profiles showed a very good agreement with those of 
simulated pH, obtained immediately after current shutdown. The simulated pH 
profile was approximately halfway between the profiles obtained in mammary 
tissue and liver tissue. If the diffusion-reaction process following treatment was 
taken into account, the model considerably overestimated the pH in tissue 
surrounding the anode. By contrast, at the higher amperage (5 mA), the 
comparison between measured and predicted pH profiles showed the correlation to 
be closest where the diffusion-reaction process was included in the simulation. 
 
The analogous destruction patterns in mammary and liver tissue support the 
hypothesis that EChT has similar results in at least these two different types of 
tissue. This implies that the destructive pattern caused by the treatment may be the 
same also in tumours. 
 
Cellular toxicity on a rat mammary tumour cell line exposed to a 
pH-gradient (Paper III) 
In EChT pH alteration in tissue is the major cause to cell damage. The aim of this 
study was to evaluate the cellular toxicity of a pH gradient on the R3230AC 
mammary tumour cell line, clone-D (kindly provided by Prof. G. Bussolati, University of Turin, Italy) in vitro. The results could be used to interpret the cell 
damaging effects seen in electrochemical treatment of tumours. 
Tumour cells were treated for 10, 20 or 30 min respectively with pH 3.5, 5, 7, 9, 
10 and 11. The following methods for detecting cellular damage were applied: 
viability assay 3-(4,5-dimethylthiazol-2-yl)-2,5,-diphenyl tetrazolium bromide 
(MTT), morphological observation in phase contrast microscope (PCM) and light 
microscope, nucleotide analogue incorporation (BrdU; 5-Bromo-2￿-deoxyuridine), 
caspase-3 activity measurement  and detection of DNA fragmentation by agarose 
gel electrophoresis.  
 
In the MTT-assay, it was found that the pH was toxic to cells in a pH-dependent 
and time-dependent manner. The effects were most prominent by pH 3.5, 10 and 
11 for 30 min (p<0.01). Morphologically, cells in pH 3.5 and 5 had shrunk, were 
round and had condensed chromatin, whereas a prominent cell swelling and 
nuclear expansion were seen in the pH 9 and 10-treated cells. Gross cytolysis was 
found in pH 11. The BrdU incorporation assay indicated that proliferation rate is 
inhibited markedly both with decreasing and increasing pH. Significant rise in the 
caspase-3 activity was found in all acidic treatment groups (p<0,05) except for pH 
5 and 20 min, still caspase-3 activity were 54% higher than normal in this group. 
The fold-increase in CPP32 activity was determined by comparing the results with 
the negative control, pH 7 (value 1). No significant differences between normal 
control and the alkaline group could be detected. Treatment of the cells with pH 
3.5 for 30 min created a pattern characteristic of internucleosomal fragmentation, 
DNA ladder (Figure 3). Treatment of the cells with other pH and duration of 
exposure did not cause marked DNA fragmentation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Detection of DNA fragmentation by agarose gel electrophoresis (1.5% agarose 
gel for 240 min at 65 V). pH-values are marked above each lane, exposure time; 30 min. 
M=DNA fragment size marker. Treatment of the cells with pH 3.5 and 30 min created a 
pattern characteristic of internucleosomal fragmentation, DNA ladder (apoptosis). 
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The pH changes inhibit proliferation and viability. The pathway of killing tumour 
cells in low pH has at least two directions; apoptosis and cell necrosis whereas 
alkaline pH results only in cell necrosis. The study suggests that low pH 
environment can induce apoptosis in unphysiological condition comparable with 
tissue pH at EChT. In addition, it seems that R3230AC mammary tumour cells are 
more tolerant to high pH than to acidic changes. This supports the theory that 
anodic EChT should be more efficient than cathodic. 
 
Electrochemical treatment in normal rat and dog liver (Paper 
IV) 
The purpose of this study was to examine whether an in vivo dose-planning model 
developed for rat liver is reliable in species with larger liver tissue mass i.e. dogs 
and eventually humans. Tissue lesions were compared between a four-electrode 
arrangement (dog) and a two-electrode EChT design (dog and rat).  Macroscopic, 
histopathological and ultrastructural findings following EChT were determined. 
 
Thirty (30) female Sprague Dawley rats and 4 female beagle dogs bred for 
research purposes only (provided by the Faculty of Veterinary Medicine, 
Department of Small Animal Clinical Sciences (SLU), Uppsala, Sweden), were 
studied with EChT during general anaesthesia. Platinum:Iridium (9:1) electrodes, 
0.5 mm in diameter with either spherical- (rat) or string- (dog) configuration were 
used and the delivered dose was 5, 10 or 90 Coulombs (As). Haematological 
values, liver enzymes (only in dogs) and acid-base balance, were determined in 
blood before and after EChT. The animals were euthanised directly after 
termination of EChT, without being allowed to wake up. The spherical (rat) or 
cylindrical (dog) volume of the lesions was determined and samples were taken 
for histopathological and ultra-structural investigations.  
 
The distribution of the lesions was predictable irrespectively of doses and 
electrode designs. Destruction volumes, calculated according to the macroscopic 
measurements, were found to fit into a logarithmic curve (dose-response). 
Histopathological examination confirmed the spherical and cylindrical/ellipsoidal 
area of tissue destruction but the type of necrosis was different at the anode and 
cathode, respectively (Figure 4).  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Histopathological examination of the normal dog liver, using two pair of 
electrodes. A) An extensive and well-defined area of coagulative necrosis is seen 
(magnification 10.5X). All four electrode lesions are seen in this large tissue section of the 
liver. The anodic lesion is dehydrated, with pycnotic nuclei and a small rim of marginal 
infarctions at the border. B) The cathodic lesions (same magnification as A) are oedematous 
with cellular swelling and occasional disruption of the plasma membranes. No infarctions 
are revealed. Both anodic and cathodic lesions have a very sharp demarcation to normal 
tissue. C) A higher magnification (420 X) of the border of destruction close to the anode. 
D) Showing the cathodic counterpart to C. 
 
Ultra-structural analysis showed distinct features of cell damage depending on the 
distance from the electrode (Figure 5a and b). Histopathological and ultra 
structural examination demonstrated that the liver tissue close to the border of the 
lesion displayed a normal morphology. 
 
The in vivo dose-planning model developed for rat liver is reliable in species with 
larger tissue mass such as dogs. A multi-electrode EChT-design could obtain 
predictable lesions and the dose-response curve suggests a logarithmic 
relationship. Moreover, the cellular toxicity following EChT is clearly identified 
and it varies with the distance from the electrode and electrode polarity. 
Furthermore, the distinct border between the lesion and normal tissue, suggests 
that EChT in a clinical setting for the treatment of liver tumours can give a reliable 
destruction margin. 
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Figure 5a and b. Ultra-
structural morphology in rat 
hepatocytes (nucleus a and 
cytoplasm b) following anodic 
EChT (5mA 10C), depending 
on the distance from the 
electrode. A shows a nucleus 
totally disrupted. B displayed 
severe damages mostly in the 
mitochondria (cytoplasm). The 
outer membranes of the 
mitochondria were well 
defined but most of the 
mitochondria matrixes were 
extracted. The peroxisomes 
were less affected but the 
matrixes were looser compared 
to controls. The granular 
endoplasmic reticulum (RER) 
was well defined and looked 
normal. Only minor changes 
were detected in the nuclear 
chromatin. C) The liver tissue 
from the border of the 
destruction had an ultra-
structural morphology that 
barely could be distinguished 
from controls. At the cathode 
no correlations, as for the 
anode, could be made between 
cellular damage and the 
distance from the treatment 
electrode (Figure not shown). 
The control (Fig 5aD and 
5bD), displayed a normal ultra-
structural morphology with 
dense mitochondria, distinct 
RER, peroxisomes and 
glycogen. Furthermore, the 
nucleus displayed natural 
euchromatin and hetero-
chromatin. Bars=1 ￿m. 
Fig. a 
 
 
 
 
 
 
Fig. b 
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Electrochemical Treatment (Paper V) 
In vivo studies were conducted to evaluate the toxic changes and effectiveness of 
EChT on an animal tumour model.  
 
Tumours were induced in twenty-eight female Fischer 344 rats weighing 
approximately 200 g by injecting 0.5x10
6 cells from the R3230AC rat mammary 
tumour cell line clone D subcutaneously into the left and right region 1 cm caudal 
to the scapula. When the tumour volumes reached approximately 400 mm
3, the 
animals were anaesthetised as earlier described in e.g. Paper I. EChT was 
conducted by inserting a thread platinum electrode into the tumour. The delivered 
doses were 10 or 20 Coulomb (C) with a constant current of 10 mA. The positive 
and negative control groups were subjected to the same conditions but without 
EChT. The negative control was injected with cell media (RPMI 1640). The rats 
were kept for 0, 7 or 14 days post treatment. Three hours prior to euthanasia an i.p. 
injection of Bromodioxyuridine (BrdU) 100 mg/kg were given. The rats were 
euthanased by administering 3 ml Na-pentobarbital 2.5% i.p., The lesions were 
extirpated and samples were collected for histopathological, and 
immunohistochemical examination.  
Histopathological changes resembled the lesions described earlier for normal 
mammary tissue in the rat. 
 
Significant changes in proliferation rate, as well as macroscopic measurable 
growth retardation, were seen both in the cathode and anode reaction, compared to 
untreated control. Apoptosis were induced in the anodic treatment (Figure 6) 
suggesting that cell destruction were caused by necrosis with cathodic EChT and 
apoptosis together with necrosis at the anode. The findings agree with the earlier 
result from Paper III, where an in vitro pH gradient exposure was applied for the 
same cell line as used in the inoculation model. 
 
 
Figure 6. Immuno fluorescence microscopic examination of apoptosis in a rat mammary 
tumour using TUNEL. A) Tumour cells at the border of destruction, anode; 20 C, 10 mA 
(objective 64 X). The nuclei show typical signs of apoptosis, with good morphology. B) 
The border of destruction around the cathode (same magnification as in A). At the cathode, 
the morphology is poor and the tumour tissue has gone into complete necrosis. 
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Discussion 
 
As in studies where new drugs are first tested on healthy patients and preceded by 
careful toxicological studies in vitro, the introduction of EChT in a clinical setting 
should be considered as no exception. While using healthy animals and one tissue 
at a time, more safe conclusions can be drawn concerning dose-planning, tissue 
destruction and immunological response to EChT, before commencing clinical 
studies on inoculated tumours and eventually cancer patients. In this way the 
number of animals used are reduced due to a more optimised research strategy and 
the studies are based on a well established hypothesis and not only on empirical 
data. 
 
We have chosen the CD-rat as an animal model for normal tissue to study the 
destruction mechanism with EChT. The change to Fischer 344 rats in the 
inoculation model was because the tumour cell line used was derived from this 
strain.  
 
In Paper I, mammary tissue in adult female rats was treated with constant direct 
current in order to investigate the influence of current level, treatment time and 
coulomb dosage on tissue destruction. The electrodes used were Pt:Ir (9:1) with 
spherical tips. This geometry generated a practical tool for comparing destructive 
effects with a proposed three-dimensional destruction in the dose-planning model 
earlier described (Nilsson, Fontes et al., 1999). Extensive in situ pH-measurements 
were performed with a micro-combination glass electrode. Macroscopic 
examination of treated mammary tissue revealed an almost spherical necrosis with 
heavy dark colour due to the heamatin produced during EChT. All of these inputs 
helped in refining the dose-planning model.  
The theoretical modelling has been presented earlier in a thesis of Nilsson 
(Nilsson, 2000). Hence, the present thesis has focused on the destructive 
properties and destruction mechanisms of EChT in vivo and in vitro. 
 
The mechanisms for cell destruction of a tumour differ between e.g. radiotherapy 
and electrolytic treatment. The limitations of radiotherapy to effectively achieve 
tumour control in the centre of a gross tumour is mainly due to the fact that a large 
portion of the cells might be hypoxic because of impaired blood supply and a high 
intratumoral pressure. A good oxygenation of the tissue will result in development 
of more oxygen radicals and more DNA-damage during radiotherapy (Riley, 
1994). In addition, peripheral parts of the tumour might periodically become 
hypoxic by shunting of the blood (Zywietz, Reeker et al., 1997). 
 
Samuelsson  et al. reported 1991 encouraging data on the combination of 
radiotherapy and EChT in tumour tissue (Samuelsson, Jonsson et al., 1991). They 
studied the effect of EChT (25 mA, 20 min) and subsequent radiotherapy, both in 
experimental tumours (malignant mesothelioma and colon carcinoma) in rats. In 
another paper Samuelsson et al. used the combination therapy on lung tumours in 
six pigs and in a single human lung tumour patient (Samuelsson, Lamm et al., 
1985). In the former study, current was supplied through two wire electrodes,   24
either copper or platinum, placed about 10 mm apart in the centre of the tumour. 
The combined treatment resulted in tumour growth inhibition and in 75% of the 
cases the tumours disappeared. In the group that received only radiotherapy, 75% 
of the tumours remained. The authors hypothesised that the inflammatory reaction 
around the electrolytic lesion lead to increased blood flow and higher oxygenation 
of the tumour, and thereby made the tumour more radiosensitive. 
 
Electrolysis can occur independently of the oxygenation status, since the cell death 
is 100% in tissue when the pH <2 (Paper I). In peripheral areas outside the gross 
tumour volume where single- or groups of tumour cells have invaded the normal 
stroma, radiation can selectively kill cancer cells while the bulk of normal cells 
will be preserved. The electrolytic technique will not be selective as far as we 
know in such an area, destroying tumour and normal cells with the same 
mechanisms, unless the electrical field can effectively kill tumour cells. This 
question needs to be investigated. Another important question to address is if it is 
possible to enhance the intended effect of ionising radiation in the target area by 
modulating the electric potential using a single electrode inserted into the tumour. 
 
The main advantage with electrolytic tumour destruction is that energy can be 
deposited into deeply situated targets without affecting tissues in the periphery of 
the target area. This can be achieved simply by isolating the part of the electrode 
that passes through the normal tissue. Even if using the most sophisticated 
conformal planning techniques for radiotherapy, ionisation of normal tissue 
surrounding the tumour will always take place to a certain degree. 
 
As described earlier, combination treatments with different chemotherapy regimes 
have been tried (Nordenstr￿m, 1983; Eksborg, Nordenstr￿m et al., 1990; Ser￿a, 
Novakovic et al., 1993). It seems that EChT can enhance tumour size reduction 
when used together e.g. with doxorubicin or bleomycin. 
 
The largest impact on tumour treatment with electric current and cytotoxic 
compounds is however the Electrochemotheraphy (Mir, Belehradek et al., 1991; 
Mir, 1994; Ser￿a, Cemazar et al., 1995). Electrochemotherapy consists of 
intravenous (or intratumourally) administration of a low dose of an antineoplastic 
e.g. bleomycin, followed by local delivery of electric pulses on tumour nodules by 
means of two electrodes located at each side of the nodule. Hence, it is not the 
electric field itself that damages the cells but the electric pulses cause an 
electropermeabilization which enhances the transport of the drug over the cell 
membrane and concentrates the drug in the tumours. This technique has recently 
been reported to be clinically used on horses with a special type of skin tumours 
called sarcoids (Rols, Tamzali et al., 2002). 
 
The tissue destruction with EChT, in large part, follows Faraday’s Law I; In any 
electrolytic process the amount of chemical change produced is proportional of the 
total amount of electrical charge passed through the cell. In Paper I the induced 
tissue damage in the low current treatment (1 mA, 5 C) was smaller than in the 
groups with higher current (2.5; 5 mA and 5 or 10 C) but not proportional 
suggesting that in vivo application of electric current may be interacted and impaired by e.g. the buffering systems. This implies that current and time, as well 
as the more commonly used coulomb dosage, should be used to a greater extent as 
dose parameters in EChT. 
 
When the electrolytic process has been in progress for some time, a marked 
dehydration occurs at the anode due to electro-osmosis. This dehydration leads to 
impairment in electrode contact and the electrolysis is hampered. Moreover, the 
impaired contact results in an acute rise in the voltage, which can be harmful to the 
patient. In order to overcome this problem, several authors have suggested the use 
of saline infusions into the anodic area (Nordenstr￿m, 1983). However, that design 
can dilute the toxic species produced during electrolysis, which in turn may reduce 
the efficacy of the treatment. Increased re-hydration can also allow the buffering 
species, whose access is hindered at the anode by the dehydration and marginal 
infarctions, to re-enter the destructive area. In Paper IV we showed that the single 
electrode model has its obvious limitations in a future clinical setting, when 
treating malignancies, due to the logarithmic dose-response curve (Figure 7). In 
the cathode lesion the dose-response curve is similar to that at the anode, which 
decreased efficacy over time. The tissue lesion is characterised by an oedema, 
which conceivably allows the buffering species to hamper the electrolysis. 
Therefore a multi-electrode set up is probably more efficient in terms of 
tissue/tumour destruction in order to use the maximal toxic capacity of each 
electrode. 
 
 
Figure 7. The chart shows the macroscopically determined volume of destruction after 
treatment with 5 and 10 C in rat liver and 90 C in dog liver. It also shows the estimated 
(Est.) dose-response curve for both anodic and cathodic EChT. The relation is almost 
logarithmic for both treatments, suggesting that the destruction volume has harder to 
propagate, as it grows larger in size. 
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In Paper II and IV we showed that the behaviour of electrochemical reaction in 
vivo is essentially the same disregarding different tissue (mammary or liver tissue) 
and different species and destruction size (liver destruction in rat versus dog). This 
is important when a comparison should be made between the many different trials 
that have been reported in the field of EChT. The differences between electrode 
materials used and the variations in combination therapies used are of course not 
applicable in this aspect. 
 
Paper IV also described that the ultra-structural features of an EChT lesion are not 
homogenous from the centre to the macroscopically visible border of the 
destruction zone. Even in light microscopy it is very hard to distinguish any 
prominent difference in the cellular morphology throughout the lesion. Electron 
microscopic analysis shows a successively milder toxic influence on the treated 
cells as the distance from the electrode centre increases at the anode. At the 
cathode, the distribution of toxic features was uneven through the investigated 
material and no correlation could be made with the distance from the treatment 
electrode. This is probably due to the oedematous environment that makes the 
￿borders￿ less accurate and the toxic species might be more easily distributed in 
the lesion, but at the same time fails to build up a high concentration. In general, 
the cathodic lesions had a milder appearance compared to the anode. The current 
ultra structural examination is easier to interpret in normal liver tissue, than in a 
malignant tumour mass since malignancies carry spontaneous necrosis and 
degenerated chromatin as a ￿normal￿ feature. However, future studies ought to be 
focused on the electrolysis and its effect on tumour tissue. 
 
In Paper III and V the influence of pH changes on the R3230AC rat mammary 
tumour cell line was investigated. The in vitro experiment showed that the 
extracellular pH change inhibits proliferation and viability. The pathway of killing 
tumour cells in low pH had at least two directions; apoptosis and cell necrosis 
(mainly apoptosis), whereas high pH resulted in cell necrosis. This entails that 
EChT, with its ability to create a fiercely toxic pH gradient, is an effective way of 
treating tumours. The following tumour inoculation experiment confirmed the 
findings in Paper III. Hence the anodic treatment with induction of apoptosis must 
be due to intratumoral acidification since no increase of apoptosis could be 
detected with the cathodic treatment. Paper V also shows that EChT gives a 
significant decrease in tumour proliferation in vivo. 
 
The development of different EChT treatment modalities is gaining increasing 
interest in the Western world. Basic investigations of the cellular behaviour in 
both normal and neoplastic tissue are good complements to the large-scale models 
and long terms studies of the safety effects of electrochemical treatment that 
recently have been published. To, in the future, anticipate the introduction of 
EChT as a complement in the treatment of tumours in humans as well as 
companion animals now appears realistic. 
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Conclusions 
 
- In the centre of the electrodes, total tissue destruction occurred. However the 
ultra-structural features of an EChT lesion is not homogenous from the centre to 
the macroscopically visible border of the destruction zone. Even in light 
microscopy it is very hard to distinguish any prominent difference in the cellular 
morphology throughout the lesion. 
 
- At the anode, a marked dehydration and acidification occurred with maintained 
tissue architecture. At the cathode, oedema and alkalisation were the dominating 
features. Moreover, the tissue lost the structural constitution.  
 
- The in vitro experiment showed that the extracellular pH change inhibits 
proliferation and viability. The pathway of killing tumour cells in low pH had at 
least two directions; apoptosis and cell necrosis (mainly apoptosis), whereas high 
pH resulted in cell necrosis. 
 
- In vivo the induction of apoptosis was concentrated to the border of destruction 
at the anode, probably due to the acidification that occurs. This is also supported 
by the in vitro study (Paper III). The cell proliferation rate was reduced 
significantly in the whole tumour, both for the anodic and cathodic treatment, 
suggesting that secondary mechanisms such as the inflammatory response, tumour 
ischemic anoxia and radical formations also impaired the tumour progression after 
EChT. Hence, the treatment had a significant effect on tumour cell￿s proliferation 
far from the evidently destroyed area. 
 
- The mathematical model predicted an acidic zone, around the anode, of about the 
same radius as that measured in mammary and liver tissue in Paper II. At the 
higher amperage (5 mA), the simulated pH profile agreed rather well with those 
observed experimentally, while the model considerably underestimated the acidity 
at the lower amperage (1 mA). The effect of a specified coulomb dose is not 
always consistent. By decreasing the treatment current, the buffer systems of the 
body can, to a larger extent, counteract the spreading of toxic species around the 
electrodes. Thus, the number of applied coulombs corresponds to the amount of 
reaction products formed at the electrodes but does not directly describe their 
distribution in tissue. The multi-electrode EChT-design used in Paper IV could 
obtain predictable lesions even in large destructions. 
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